Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this clinical trial is to investigate the safety
(with emphasis on hypoglycaemia) after switching from long-acting insulin analogue or
intermediate-acting insulin to insulin degludec (NN1250, SIBA) on a basal-bolus regimen in
subjects with type 1 diabetes mellitus.